Hims & Hers aired a controversial advertisement during the Super Bowl, targeting the obesity epidemic and promoting its weight-loss products. The ad drew criticism from both pharmaceutical trade groups and U.S. senators, who expressed their concerns to the FDA regarding the potential for misleading information, particularly due to the lack of safety and side effects disclosures. Notably, the ad featured injection pens and highlighted the weight loss industry without adequately addressing the FDA status of the products. Hims & Hers asserted compliance with existing regulations amid the scrutiny.
Hims & Hers ran a controversial Super Bowl ad addressing the obesity epidemic, prompting concerns from the FDA and U.S. officials about misleading health information.
Collection
[
|
...
]